Coty Likely To Report Q4 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Coty Inc. is slated to report Q4 financial results on August 20, with analysts forecasting earnings of 2 cents per share on revenue of $1.21 billion. This upcoming report follows the company's worse-than-expected Q3 performance and a subsequent cut to its FY25 adjusted EPS guidance. Coty shares closed down 1.8% at $4.89 on Tuesday, reflecting a broader cautious sentiment among analysts, as multiple firms including JP Morgan, Goldman Sachs, and BofA Securities have recently downgraded ratings or significantly cut price targets.

Analysis

Coty Inc. is approaching its fourth-quarter earnings report on August 20 under significant negative sentiment, stemming from a poor third-quarter performance and a subsequent reduction in its fiscal year 2025 adjusted EPS guidance. While analysts forecast a shift to a quarterly profit of 2 cents per share from a loss of 3 cents a year ago, this is overshadowed by a projected significant year-over-year revenue decline to $1.21 billion from $1.36 billion. This top-line pressure is reflected in a wave of recent bearish analyst actions. Notably, B of A Securities and Canaccord Genuity have downgraded the stock to Underperform and Hold, respectively, while JP Morgan, Goldman Sachs, and Wells Fargo have all enacted substantial price target cuts, with new targets clustering between $4.50 and $6.00. The stock’s recent 1.8% drop to $4.89 indicates that the market is pricing in these concerns and the heightened risk ahead of the financial disclosure.

Key Decisions for Investors

• Investors should be cautious, as the consensus of analyst downgrades and significant price target reductions from firms like B of A Securities and Goldman Sachs points to a deteriorating fundamental outlook.
• The primary focus for the upcoming earnings call should be on the drivers of the projected 11% year-over-year revenue decline and any management commentary regarding margin pressures or outlook for FY25.
• Given that current analyst price targets offer limited upside from the stock's $4.89 price, holding or initiating a long position carries elevated risk until the company can demonstrate a clear path to reversing its top-line contraction and meeting its revised guidance.